15-Apr-2026 3:15 PM CST - Business Wire IQVIA to Announce First-Quarter 2026 Results on May 5, 2026 IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its first-quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release and accompanying fin
24-Mar-2026 11:10 AM CST - Yahoo Finance TD Cowen Upgrades IQVIA (IQV) to Buy and Raises Price Target to $213 IQVIA Holdings Inc. (NYSE:IQV) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. On March 9, 2026, TD Cowen upgraded its rating on IQVIA Holdings Inc. (NYSE:IQV) from Hold to Buy.
12-Mar-2026 2:12 PM CST - Seeking Alpha IQVIA Holdings Inc. (IQV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Good morning, everybody. Luke Sergott. I cover life science tools and diagnostics for Barclays. With me, I have Mike Fedock, CFO of IQVIA. Yes, yes, absolutely. No, great question and obviously incredibly timely. Firstly, this AI phenomenon's has -- it's a ...
11-Mar-2026 1:00 PM CST - Yahoo Finance IQVIA Expands In Vitro Discovery Footprint As Shares Face Pressure IQVIA Holdings (NYSE:IQV) has agreed to acquire discovery services assets from Charles River Laboratories. The deal adds in vitro discovery capabilities across five additional sites to IQVIA's existing network.
10-Mar-2026 1:30 PM CST - Yahoo Finance Is IQVIA Holdings Stock Underperforming the Nasdaq? IQVIA Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock's prospects.
2-Mar-2026 3:35 PM CST - Yahoo Finance Analysts at Mizuho Remain Bullish on IQVIA (IQV) Following Q4 Results IQVIA Holdings Inc. (NYSE:IQV) is one of the most undervalued AI stocks to buy now. With significant analyst and hedge fund sentiment, alongside a low forward price-to-earnings (PE) ratio, IQVIA Holdings Inc.
2-Mar-2026 3:30 PM CST - Business Wire IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Mike Fedock, executive vice president and chief financial officer, will speak at the Barclays 28th Annual Global Healthcare Conference on Thursday, March 12, 2026, at 9:30 a.m. ET. A live audio webcast of the presentation will be availa
2-Mar-2026 3:15 PM CST - Business Wire IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9, 2026, at 9:20 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA I
26-Feb-2026 1:07 AM CST - Yahoo Finance IQVIA Acquisition Expands Drug Discovery Role And Highlights Valuation Gap IQVIA Holdings (NYSE:IQV) agreed to acquire discovery services assets from Charles River Laboratories. The deal focuses on in vitro discovery services and a small molecule AI platform that support non animal research methods.
Latest IQV Trades by Congress Members
16-MAR-2026 - Kevin Hern, OK (District 1) sold between $50,001 and $100,000.
15-Apr-2026 3:15 PM CST - Business Wire IQVIA to Announce First-Quarter 2026 Results on May 5, 2026 IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its first-quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release and accompanying fin
24-Mar-2026 11:10 AM CST - Yahoo Finance TD Cowen Upgrades IQVIA (IQV) to Buy and Raises Price Target to $213 IQVIA Holdings Inc. (NYSE:IQV) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. On March 9, 2026, TD Cowen upgraded its rating on IQVIA Holdings Inc. (NYSE:IQV) from Hold to Buy.
12-Mar-2026 2:12 PM CST - Seeking Alpha IQVIA Holdings Inc. (IQV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Good morning, everybody. Luke Sergott. I cover life science tools and diagnostics for Barclays. With me, I have Mike Fedock, CFO of IQVIA. Yes, yes, absolutely. No, great question and obviously incredibly timely. Firstly, this AI phenomenon's has -- it's a ...
11-Mar-2026 1:00 PM CST - Yahoo Finance IQVIA Expands In Vitro Discovery Footprint As Shares Face Pressure IQVIA Holdings (NYSE:IQV) has agreed to acquire discovery services assets from Charles River Laboratories. The deal adds in vitro discovery capabilities across five additional sites to IQVIA's existing network.
10-Mar-2026 1:30 PM CST - Yahoo Finance Is IQVIA Holdings Stock Underperforming the Nasdaq? IQVIA Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock's prospects.
2-Mar-2026 3:35 PM CST - Yahoo Finance Analysts at Mizuho Remain Bullish on IQVIA (IQV) Following Q4 Results IQVIA Holdings Inc. (NYSE:IQV) is one of the most undervalued AI stocks to buy now. With significant analyst and hedge fund sentiment, alongside a low forward price-to-earnings (PE) ratio, IQVIA Holdings Inc.
2-Mar-2026 3:30 PM CST - Business Wire IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Mike Fedock, executive vice president and chief financial officer, will speak at the Barclays 28th Annual Global Healthcare Conference on Thursday, March 12, 2026, at 9:30 a.m. ET. A live audio webcast of the presentation will be availa
2-Mar-2026 3:15 PM CST - Business Wire IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9, 2026, at 9:20 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA I
26-Feb-2026 1:07 AM CST - Yahoo Finance IQVIA Acquisition Expands Drug Discovery Role And Highlights Valuation Gap IQVIA Holdings (NYSE:IQV) agreed to acquire discovery services assets from Charles River Laboratories. The deal focuses on in vitro discovery services and a small molecule AI platform that support non animal research methods.
